FDA
-
-
-
-
-
-
-
Cellceutix AACR Poster Presents Data Supporting Kevetrin Modulation of p53 in Multiple Human Ovarian Cancer Cell-lines and Corresponding Xenograft Tumors
-
-
-
-
-
-
-
Cellceutix Reports on Q2 Fiscal 2017, Prepares for Important Clinical Milestones
-
-
-
-
-
-
324,249 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

